Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Edition  2008: Volume 13/ Issue 15 Article 1
Back to Table of Contents
Download (pdf)
Next

Eurosurveillance, Volume 13, Issue 15, 10 April 2008
Rapid communications
Measles outbreaks in London, United Kingdom - a preliminary report
  1. South East London Health Protection Unit, London, United Kingdom
  2. Lewisham Primary Care Trust, London, United Kingdom

Citation style for this article: Heathcock R, Watts C. Measles outbreaks in London, United Kingdom - a preliminary report. Euro Surveill. 2008;13(15):pii=18829. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18829
Date of submission: 09 April 2008

 

2007 saw the highest number of measles cases reported in England and Wales since current surveillance began in 1995, with 971 confirmed cases reported, compared with 740 reported in 2006 [1]. London was the region with the highest number of cases, and a large outbreak of measles in north-east London contributed to this high number of cases [2]. There were several outbreaks of measles elsewhere in Europe in 2007, and case have been reported this year in Switzerland [3], France [4] and Denmark [5].

Measles also continues to circulate in the greater London area during 2008. In Lewisham, a local authority area in south-east London, there has been a marked increase in cases so far during 2008.

A total of 19 laboratory-confirmed and 63 probable measles cases have been reported in Lewisham between 1 January 2008 and 8 April. This compares with provisional figures of fewer than 20 cases for the whole of 2007. There have been a number of outbreaks this year, including one in the local hospital, where nine cases were linked to a child admitted to the paediatric ward. This child subsequently developed measles. Cases are being seen in all age groups, although children younger than five years old are particularly affected, with six confirmed and 18 probable cases. There are ongoing outbreaks in two schools, reflected in the number of cases in 10-19 year olds, with nine confirmed and 29 probable cases. There have been four probable cases in people older than 20 years. A representative strain has been genotyped, and is identical to MVs/Enfield.GBR/14.07 genotype D4 (GenBank EF 600554) (Health Protection Agency, Virus Reference Department, Centre for Infections).

Lewisham, along with many parts of London, has historically had a low uptake of the measles, mumps and rubella (MMR) vaccine. Coverage of the first dose of MMR vaccine in two-year-olds during 2006-07 was 67 percent [6] and for two doses of MMR in five-year-olds was only 48 percent. The recorded coverage for the September 2007 quarter was 64 percent. Although it is likely that the uptake is in fact higher than this, due to problems in ensuring data accuracy, the uptake remains well below the 95 percent target.

There are several factors likely to have contributed to the low uptake in this area. Traditionally, these include socio-economic factors, such as high population mobility, family size, chronically ill children in the family, affecting access to services. Lewisham is an inner-city area with high levels of deprivation. There are increasing signs that the middle classes in the United Kingdom may also now be an at-risk group [7,8], due to parents' active decisions not to immunise their children with the MMR vaccine. Anecdotal evidence from the follow-up of individual cases in Lewisham by the South East London Health Protection Unit suggests that some parents of cases had also taken this decision.

Control measures
The local health authority, Lewisham Primary Care Trust, has declared a major community outbreak and is putting in place a range of control measures, supported by the Health Protection Unit. These include raising awareness in the population; encouraging MMR uptake with proactive media releases; dissemination of information to schools and nurseries in the area, including advice on exclusion; alerting health professionals; and offering MMR at additional community clinics. The overall aim is to increase MMR uptake in children in Lewisham both in the short and longer term.


References

  1. HPA. Confirmed measles mumps and rubella cases in 2007: England and Wales. Health Protection Report. 2008;[cited 9 April 2008];2(8). Available from: http://www.hpa.org.uk/hpr/archives/2008/hpr0808.pdf
  2. Ashmore J, Addiman S, Cordery R, Maguire H. Measles in North East and North Central London, England: a situation report. Euro Surveill. 2007;12(9):E070920.2. Available from: http://www.eurosurveillance.org/ew/2007/070920.asp#2
  3. Measles outbreak in Switzerland - an update relevant for the European football championship (EURO 2008). Euro Surveill. 2008;13(8). Available from: http://www.eurosurveillance.org/edition/v13n08/080221_1.asp
  4. An outbreak of measles in Reims, eastern France, January-March 2008 - a preliminary report. Euro Surveill. 2008;13(13). Available from: http://www.eurosurveillance.org/edition/v13n13/080327_1.asp
  5. A cluster of measles cases in Denmark following importation, January and February 2008. Euro Surveill. 2008;13(9). Available from: http://www.eurosurveillance.org/edition/v13n09/080228_1.asp
  6. The Information Centre. NHS Immunisation Statistics England 2006-07. Available from: http://www.ic.nhs.uk/webfiles/publications/immstats2005to2006/Final%202006-07%20Immunisation%20Bulletin%20%28with%20copyright%29.pdf
  7. McIntyre P, Leask J. Improving uptake of MMR vaccine. BMJ. 2008;336:729-730.
  8. Cleverly I. Rash decisions. The Guardian [online version]. April 7 2008. Available from: http://commentisfree.guardian.co.uk/ian_cleverly/2008/04/rash_decisions_1.html

 



Back to Table of Contents
Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.